ICICI Prudential Mutual Fund · #153458
ICICI Prudential Quality Fund - Direct Plan - Growth
Equity · Sectoral/ Thematic · Direct · Growth
Direct TER: 1.40% · as of
5-year NAV · change the window using the controls in the rolling-returns card below ↓
2025-05-26 → 2026-10-22
Latest NAV
₹10.3000
as of 2026-10-22 · -0.58% vs 2026-10-21
Earliest NAV in archive
2025-05-26
AMFI archive begins Apr 2006
Trailing CAGR vs assigned benchmark
| Window | Scheme CAGR | Benchmark CAGR | Excess | Period |
|---|---|---|---|---|
| 1y | -2.00% | -8.70%* | +6.69% | 2025-10-23 → today · 1.0y |
Benchmark assignment is mapped by category and sub-category from public sources.
* The total-return version of this benchmark is no longer published,
so starred rows use its price index, which excludes dividends. That understates the benchmark by roughly its
dividend yield (about 1.2% a year) and overstates Excess by the same.
"Since inception (in archive)" uses the earliest NAV in the AMFI archive (April 2006 onward).
Rolling 1-year returns distribution · 103 daily entry points · last 5 years
Imagine buying this fund on any day in this period and holding for exactly one year. Each bar counts how often that ended with a given return: green bars made money, red bars lost money even after a full year. Taller bar = more common outcome.
Median 1y return
+3.2%
Mean 1y return
+3.9%
Best / worst 1y
+10.4% / -2.5%
Windows positive
93%
Monthly returns · since inception (May 2025)
How each calendar month went: green months gained, red months lost. Deeper colour = bigger move.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.7 | -0.4 | -9.4 | +8.1 | +0.2 | +2.5 | +4.2 | +1.6 | -5.4 | -1.2 | · | · | -3.6 |
| 2025 | · | · | · | · | · | +2.7 | -1.6 | -0.2 | -0.4 | +3.9 | +1.9 | +0.1 | +6.4 |
| Avg | -2.7 | -0.4 | -9.4 | +8.1 | +0.2 | +2.6 | +1.3 | +0.7 | -2.9 | +3.9 | +1.9 | +0.1 | · |
All values in %. Each cell compares the last NAV of the month with the last NAV of the month before. The latest month is month-to-date; the Year column compounds the months shown on that row.
Portfolio mix · asset class breakdown as of 2026-09-30
Size axis (Style Box) · Large / Mid / Small split of latest disclosed holdings
Per AMFI's semi-annual Categorisation of Stocks (top 100 = Large, 101-250 = Mid, 251+ = Small).
- Large Cap 56.0%
- Mid Cap 12.0%
- Small Cap 23.9%
- Cash & Equivalents 4.4%
- Unlisted & other equity 3.7%
Index overlap
· vs · share of this fund's AUM that sits in stocks the index also includes82.1%
58 of 71 holdings are index members
Almost all holdings are in the benchmark universe
As of 2026-09-30
How to read this: This number shows whether the fund invests in the same stocks as the index. It does not show whether the fund weights those stocks like the index. A low number (say below 60%) means the fund holds a meaningful share in stocks the index doesn't carry at all (typical of sectoral, small-cap-tilted or international funds vs a broad benchmark). A high number (80%+) is normal for any large-cap or flexi-cap fund, because Indian active funds mostly pick from the same large and mid-cap stocks as the Nifty 500. It does not on its own signal a closet index fund; to identify that you'd need per-stock weight comparison, which requires index constituent weights we don't currently ingest.
Top stocks held · 71 holdings as of 2026-09-30 See changes vs previous snapshot →
| Stock | Sector | % of fund |
|---|---|---|
| ICICI Bank Ltd. | Banks | 6.50% |
| Bharat Electronics Ltd. | Aerospace & Defense | 4.18% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 4.06% |
| HDFC Bank Ltd. | Banks | 3.90% |
| Mahindra & Mahindra Ltd. | Automobiles | 3.40% |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 2.87% |
| Hindustan Unilever Ltd. | Diversified Fmcg | 2.65% |
| Astrazeneca Pharma India Ltd. | Pharmaceuticals & Biotechnology | 2.50% |
| TD Power Systems Ltd. | Electrical Equipment | 2.12% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.01% |
| Bajaj Finserv Ltd. | Finance | 1.92% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 1.90% |
| Eicher Motors Ltd. | Automobiles | 1.82% |
| Tech Mahindra Ltd. | It - Software | 1.82% |
| Tata Consultancy Services Ltd. | It - Software | 1.80% |
| Cholamandalam Investment And Finance Company Ltd. | Finance | 1.78% |
| Mphasis Ltd. | It - Software | 1.75% |
| COFORGE Ltd. | It - Software | 1.73% |
| Rentomojo Ltd. | Commercial Services & Supplies | 1.57% |
| Godrej Consumer Products Ltd. | Personal Products | 1.56% |
Sector mix
- Financial Services 25.0%
- Healthcare 22.6%
- Capital Goods 17.8%
- Information Technology 9.4%
- Automobile and Auto Components 7.5%
- Fast Moving Consumer Goods 6.2%
- Services 4.2%
- Other 7.3%
Risk metrics, trailing 3y (268 matched daily returns, 2025-05-27 → 2026-06-30)
Calmar
—
CAGR / |max DD| in window
Risk-free rate assumed 6.0% annualised. Benchmark = Nifty 500 TRI (assigned by category mapping).
Factual data only. No investment advice or recommendation. Read the scheme document and consult a SEBI-registered Investment Adviser for personalised guidance.